A citation-based method for searching scientific literature

Thomas Dörner, Richard Furie. Lancet 2019
Times Cited: 107







List of co-cited articles
423 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri, Ana-Maria Orbai, Graciela S Alarcón, Caroline Gordon, Joan T Merrill, Paul R Fortin, Ian N Bruce, David Isenberg, Daniel J Wallace, Ola Nived,[...]. Arthritis Rheum 2012
18

Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
Eric F Morand, Richard Furie, Yoshiya Tanaka, Ian N Bruce, Anca D Askanase, Christophe Richez, Sang-Cheol Bae, Philip Z Brohawn, Lilia Pineda, Anna Berglind,[...]. N Engl J Med 2020
221
17

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Antonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, Martin Aringer, Ingeborg Bajema, John N Boletis, Ricard Cervera, Andrea Doria, Caroline Gordon, Marcello Govoni,[...]. Ann Rheum Dis 2019
415
14

Systemic lupus erythematosus.
George C Tsokos. N Engl J Med 2011
13


New insights into the immunopathogenesis of systemic lupus erythematosus.
George C Tsokos, Mindy S Lo, Patricia Costa Reis, Kathleen E Sullivan. Nat Rev Rheumatol 2016
412
11

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Daniel J Wallace, Richard A Furie, Yoshiya Tanaka, Kenneth C Kalunian, Marta Mosca, Michelle A Petri, Thomas Dörner, Mario H Cardiel, Ian N Bruce, Elisa Gomez,[...]. Lancet 2018
184
10

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
9

Systemic lupus erythematosus.
Arvind Kaul, Caroline Gordon, Mary K Crow, Zahi Touma, Murray B Urowitz, Ronald van Vollenhoven, Guillermo Ruiz-Irastorza, Graham Hughes. Nat Rev Dis Primers 2016
286
9

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.
Martin Aringer, Karen Costenbader, David Daikh, Ralph Brinks, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen,[...]. Ann Rheum Dis 2019
223
9

The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.
Caroline Gordon, Maame-Boatemaa Amissah-Arthur, Mary Gayed, Sue Brown, Ian N Bruce, David D'Cruz, Benjamin Empson, Bridget Griffiths, David Jayne, Munther Khamashta,[...]. Rheumatology (Oxford) 2018
112
8

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
364
8

Systemic lupus erythematosus.
Larissa Lisnevskaia, Grainne Murphy, David Isenberg. Lancet 2014
375
7

Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
George K Bertsias, Maria Tektonidou, Zahir Amoura, Martin Aringer, Ingeborg Bajema, Jo H M Berden, John Boletis, Ricard Cervera, Thomas Dörner, Andrea Doria,[...]. Ann Rheum Dis 2012
585
7

New therapies for systemic lupus erythematosus - past imperfect, future tense.
Grainne Murphy, David A Isenberg. Nat Rev Rheumatol 2019
56
12

The immune cell landscape in kidneys of patients with lupus nephritis.
Arnon Arazi, Deepak A Rao, Celine C Berthier, Anne Davidson, Yanyan Liu, Paul J Hoover, Adam Chicoine, Thomas M Eisenhaure, A Helena Jonsson, Shuqiang Li,[...]. Nat Immunol 2019
177
6

Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.
Jing He, Xia Zhang, Yunbo Wei, Xiaolin Sun, Yaping Chen, Jun Deng, Yuebo Jin, Yuzhou Gan, Xin Hu, Rulin Jia,[...]. Nat Med 2016
266
6

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T Merrill, W Winn Chatham,[...]. Arthritis Rheum 2011
797
6


2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
Martin Aringer, Karen Costenbader, David Daikh, Ralph Brinks, Marta Mosca, Rosalind Ramsey-Goldman, Josef S Smolen, David Wofsy, Dimitrios T Boumpas, Diane L Kamen,[...]. Arthritis Rheumatol 2019
286
6

The classification of glomerulonephritis in systemic lupus erythematosus revisited.
Jan J Weening, Vivette D D'Agati, Melvin M Schwartz, Surya V Seshan, Charles E Alpers, Gerald B Appel, James E Balow, Jan A Bruijn, Terence Cook, Franco Ferrario,[...]. Kidney Int 2004
835
6


Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.
C Bombardier, D D Gladman, M B Urowitz, D Caron, C H Chang. Arthritis Rheum 1992
6

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Bevra H Hahn, Maureen A McMahon, Alan Wilkinson, W Dean Wallace, David I Daikh, John D Fitzgerald, George A Karpouzas, Joan T Merrill, Daniel J Wallace, Jinoos Yazdany,[...]. Arthritis Care Res (Hoboken) 2012
734
5

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Munther Khamashta, Joan T Merrill, Victoria P Werth, Richard Furie, Kenneth Kalunian, Gabor G Illei, Jorn Drappa, Liangwei Wang, Warren Greth. Ann Rheum Dis 2016
269
5

Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus.
Richard Furie, Victoria P Werth, Joseph F Merola, Lauren Stevenson, Taylor L Reynolds, Himanshu Naik, Wenting Wang, Romy Christmann, Agnes Gardet, Alex Pellerin,[...]. J Clin Invest 2019
84
5

The global burden of SLE: prevalence, health disparities and socioeconomic impact.
Erin E Carter, Susan G Barr, Ann E Clarke. Nat Rev Rheumatol 2016
149
5

Systemic lupus erythematosus: Diagnosis and clinical management.
Andrea Fava, Michelle Petri. J Autoimmun 2019
101
4

Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices.
Ingeborg M Bajema, Suzanne Wilhelmus, Charles E Alpers, Jan A Bruijn, Robert B Colvin, H Terence Cook, Vivette D D'Agati, Franco Ferrario, Mark Haas, J Charles Jennette,[...]. Kidney Int 2018
149
4

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis, James C Oates, Tammy O Utset, Caroline Gordon, David A Isenberg, Hsin-Ju Hsieh,[...]. Arthritis Rheum 2010
732
4

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
Brad H Rovin, Richard Furie, Kevin Latinis, R John Looney, Fernando C Fervenza, Jorge Sanchez-Guerrero, Romeo Maciuca, David Zhang, Jay P Garg, Paul Brunetta,[...]. Arthritis Rheum 2012
694
4

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.
Tobias Alexander, Ramona Sarfert, Jens Klotsche, Anja A Kühl, Andrea Rubbert-Roth, Hannes-Martin Lorenz, Jürgen Rech, Bimba F Hoyer, Qingyu Cheng, Aderajew Waka,[...]. Ann Rheum Dis 2015
185
4

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.
Jing He, Ruijun Zhang, Miao Shao, Xiaozhen Zhao, Miao Miao, Jiali Chen, Jiajia Liu, Xiaoying Zhang, Xia Zhang, Yuebo Jin,[...]. Ann Rheum Dis 2020
68
5

Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction.
Yasuko Furumoto, Carolyne K Smith, Luz Blanco, Wenpu Zhao, Stephen R Brooks, Seth G Thacker, Zarzour Abdalrahman, Giuseppe Sciumè, Wanxia L Tsai, Anna M Trier,[...]. Arthritis Rheumatol 2017
110
4

The pathogenesis of rheumatoid arthritis.
Iain B McInnes, Georg Schett. N Engl J Med 2011
4


Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus.
Scott A Jenks, Kevin S Cashman, Esther Zumaquero, Urko M Marigorta, Aakash V Patel, Xiaoqian Wang, Deepak Tomar, Matthew C Woodruff, Zoe Simon, Regina Bugrovsky,[...]. Immunity 2018
224
4

Identification and Characterization of Post-activated B Cells in Systemic Autoimmune Diseases.
Sarah Y Weißenberg, Franziska Szelinski, Eva Schrezenmeier, Ana-Luisa Stefanski, Annika Wiedemann, Hector Rincon-Arevalo, Anna Welle, Annemarie Jungmann, Karl Nordström, Jörn Walter,[...]. Front Immunol 2019
19
21

Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients.
Romain Banchereau, Seunghee Hong, Brandi Cantarel, Nicole Baldwin, Jeanine Baisch, Michelle Edens, Alma-Martina Cepika, Peter Acs, Jacob Turner, Esperanza Anguiano,[...]. Cell 2016
249
4

Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.
Gina S Garcia-Romo, Simone Caielli, Barbara Vega, John Connolly, Florence Allantaz, Zhaohui Xu, Marilynn Punaro, Jeanine Baisch, Cristiana Guiducci, Robert L Coffman,[...]. Sci Transl Med 2011
775
4

A CD4+ T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate.
Simone Caielli, Diogo Troggian Veiga, Preetha Balasubramanian, Shruti Athale, Bojana Domic, Elise Murat, Romain Banchereau, Zhaohui Xu, Manjari Chandra, Cheng-Han Chung,[...]. Nat Med 2019
84
4

Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways.
Evan Der, Hemant Suryawanshi, Pavel Morozov, Manjunath Kustagi, Beatrice Goilav, Saritha Ranabothu, Peter Izmirly, Robert Clancy, H Michael Belmont, Mordecai Koenigsberg,[...]. Nat Immunol 2019
118
4

Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus.
Christopher M Tipton, Christopher F Fucile, Jaime Darce, Asiya Chida, Travis Ichikawa, Ivan Gregoretti, Sandra Schieferl, Jennifer Hom, Scott Jenks, Ron J Feldman,[...]. Nat Immunol 2015
231
4


Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
Grainne Murphy, Larissa Lisnevskaia, David Isenberg. Lancet 2013
79
3

Infectious processes and systemic lupus erythematosus.
Rebeca Illescas-Montes, Claudia Cristina Corona-Castro, Lucia Melguizo-Rodríguez, Concepción Ruiz, Víctor J Costela-Ruiz. Immunology 2019
27
11

Therapeutic advances in the treatment of SLE.
Ali Mohamed, Yongjian Chen, Haijing Wu, Jieyue Liao, Bo Cheng, Qianjin Lu. Int Immunopharmacol 2019
11
27


New therapeutic strategies in systemic lupus erythematosus management.
Mariele Gatto, Margherita Zen, Luca Iaccarino, Andrea Doria. Nat Rev Rheumatol 2019
41
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.